首页 Penumbra(usPEN)-基本信息

Penumbra(usPEN)-基本信息

日报更新时间:

周报更新时间:04-11 03:39

行情信息

今开价:274.34

最高价:275.66

成交量:248040.0

昨收价:272.06

最低价:266.56

最新价:272.03

行情图标
概要信息

英文名称:Penumbra


简介:Penumbra, Inc.于2004年作为特拉华州公司成立。该公司是一家全球性介入治疗公司,专注于设计,开发,制造和销售创新的医疗设备。公司拥有解决具有挑战性的医疗条件和跨越两大市场显著的临床需求,神经及周围血管有广泛的产品组合。它的产品地址包括缺血性中风,出血性中风,以及可以通过血栓和栓塞程序待治疗各种周围血管


电话:1-510-7483200


最新量化综合结论
百科信息
  • 相关网站
  • 百科
  • 员工交易记录
  • 持股信息
  • 领导人信息

Penumbra公司是一家专注神经系统疾病治疗的公司,最近将业务扩展到了血管疾病领域,而在两大具有挑战的医疗领域——神经系统疾病和血管疾病,都具有广泛的产品组合和优越的医疗条件,公司产品主要用以治疗:缺血性中风、出血性中风、血管堵塞、血管破裂、血栓和栓塞等。Penumbra公司主要通过其销售队伍和销售代理商在美国国内和全球销售其产品。Penumbra(PEN)大事记: 2007年,在美国推出公司第一款产品——神经血管内窥装置(翻译可能存在误差,原文:neurovascular access); 2008年,Penumbra在美国和欧洲建立了专业的神经疾病设备直销队伍; 2008年,为缺血性中风患者的治疗推出首款吸入型产品——510(k)-cleared,之后,该产品先后推出了4代; 2011年,Penumbra推出首款用于脑动脉瘤治疗的神经血管线圈(neurovascular coil); 2013年,Penumbra推出首款外周血管产品(peripheral vascular product); 2014年,Penumbra在美国和欧洲建立了专业的外周血管产品直销队伍; 截止2015年6月30日,公司全球员工人数达到1000人。

交易日期 交易人 职位 类型 交易份额 价格
2017-08-08 Evans (Robert D) General Counsel Sell 700 86.35
2017-08-08 Evans (Robert D) General Counsel Sell 9300 85.06
2017-07-31 Davis (Daniel Donen) Officer Buy 30559 12.36
2017-07-31 Davis (Daniel Donen) Officer Sell 6850 78.31
2017-07-31 Davis (Daniel Donen) Officer Sell 2763 80.98
2017-07-31 Davis (Daniel Donen) Officer Sell 7954 80.19
2017-07-31 Davis (Daniel Donen) Officer Sell 14433 79.22
2017-07-20 Evans (Robert D) General Counsel Buy 4629 22.04
2017-07-17 Wilder (Thomas C III) Director Sell 345 86.10
2017-04-27 Kosaraju (Sridhar) Officer Sell 82029 85.45
2017-04-23 Evans (Robert D) General Counsel Buy 5000 22.04
2017-04-23 Evans (Robert D) General Counsel Sell 5000 85.24
2017-04-23 Evans (Robert D) General Counsel Sell 5000 85.24
2017-04-20 O'Rourke (Bridget) Director Buy 1418 --
2017-04-20 O'Rourke (Bridget) Director Buy 827 --
2017-04-16 Grewal (Harpreet S) Director Buy 1448 --
2017-04-16 Wilder (Thomas C III) Director Buy 1448 --
2017-04-16 Kassing (Don W) Director Buy 1448 --
2017-02-28 Evans (Robert D) General Counsel Sell 5000 80.03
2017-02-13 Rothman (Lynn) Officer Sell 6000 75.00
2017-02-13 Evans (Robert D) General Counsel Sell 5000 75.00
2017-02-12 Elsesser (Adam) Chief Executive Officer Sell 400 73.44
2017-02-12 Pray (James Robert) Officer Sell 500 73.50
2017-02-12 Kosaraju (Sridhar) Officer Sell 200 74.30
2017-02-12 Kosaraju (Sridhar) Officer Sell 600 73.28
2017-02-12 Pray (James Robert) Officer Sell 1000 72.52
2017-02-12 Bose (Arani) Officer and Director Sell 1000 72.49
2017-02-12 Bose (Arani) Officer and Director Buy 1600 1.26
2017-02-12 Elsesser (Adam) Chief Executive Officer Sell 200 74.33
2017-02-12 Elsesser (Adam) Chief Executive Officer Sell 1000 72.50
第 页, 共 15 页 首页 上页 下页 末页

机构持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
William Blair Investment Management, LLC 686813 1.98% -4089 -0.59% 2019-03-31
Morgan Stanley Investment Management, Inc. 2153795 6.20% 1437841 200.83% 2019-03-31
Fidelity SelectCo, LLC 2182059 6.28% -- -- 2019-07-31
Morgan Stanley - Brokerage Accounts 2183124 6.28% 1454024 199.43% 2019-03-31
Fidelity Management & Research Company 2296689 6.61% -176872 -7.15% 2019-07-31
Wellington Management Company LLP 2574047 7.41% 522714 25.48% 2019-03-31
Vanguard Group Inc 2920069 8.41% 19478 0.67% 2019-03-31
Fidelity Management and Research Company 5133152 14.78% 166936 3.36% 2019-03-31
FMR Inc 5197972 14.96% 173056 3.44% 2019-03-31
BlackRock Inc 1521864 4.38% -57141 -3.62% 2019-03-31
BlackRock Fund Advisors 1468210 4.23% 4631 0.32% 2019-07-31
Hartford Funds Management Company, LLC 1182475 3.40% -31227 -2.57% 2019-07-31
Partner Fund Management LP 727057 2.09% -175841 -19.48% 2019-03-31
Fidelity Management Trust Co 751952 2.16% -9877 -1.30% 2019-07-31
T. Rowe Price Associates, Inc. 810194 2.33% 94085 13.14% 2019-03-31
ClearBridge Advisors, LLC 813016 2.34% 74377 10.07% 2019-03-31
Vanguard Investments Australia Ltd 867776 2.50% -11 -- 2019-07-31
AllianceBernstein L.P. 917467 2.64% 20284 2.26% 2019-03-31
Baillie Gifford & Co Limited. 924904 2.66% 18882 2.08% 2019-03-31
Vanguard 964130 2.78% 187346 24.12% 2019-07-31
Putnam Investments LLC 702799 2.02% -4616 -0.65% 2018-12-31
Putnam Investment Management, LLC 701260 2.02% -5500 -0.78% 2019-02-28
State Street Corporation 512475 1.49% 58705 12.94% 2018-09-30
Putnam Investment Management,LLC 640504 1.86% -50686 -7.33% 2018-06-30
BlackRock Institutional Trust Company NA 841319 2.44% -38112 -4.33% 2018-06-30
Lord, Abbett & Co LLC 812378 2.35% 256348 46.10% 2018-06-30
AllianceBernstein LP 775362 2.26% -260305 -25.13% 2018-06-30
Morgan Stanley Investment Management Inc 516639 1.51% -32059 -5.84% 2018-06-30
State Street Corp 453770 1.32% -156043 -25.59% 2018-06-30
Eagle Asset Management, Inc. 419484 1.22% -1389 -0.33% 2018-06-30
Legg Mason Partners Fund Advisor, LLC 400132 1.16% 6910 1.76% 2018-09-12
Invesco Advisers, Inc 394387 1.15% -88089 -18.26% 2018-06-30
Millennium Management LLC 375070 1.09% 305161 436.51% 2018-06-30
Federated Global Inv Mgmt Corp 437165 1.28% -36500 -7.71% 2018-03-31
1832 Asset Management L.P 346500 0.99% 346500 -- 2018-06-30
Champlain Investment Partners, LLC 329590 0.96% -64620 -16.39% 2018-06-30
Franklin Advisers Inc 322423 0.94% -491 -0.15% 2018-06-30
Northern Trust Investments N A 367453 1.07% -619 -0.17% 2018-03-31
American Century Inv Mgt Inc 319176 0.93% -8145 -2.49% 2018-06-30
Waddell & Reed Investment Management Co 400825 1.17% -72180 -15.26% 2018-03-31
Redmile Group, LLC 547079 1.60% -70200 -11.37% 2018-03-31
Ameriprise Financial Inc 391000 1.14% 391000 -- 2018-03-31
Columbia Wanger Asset Management LLC 391000 1.14% 140000 55.78% 2018-03-31
Carret & Company Inc 468836 1.39% -9025 -1.89% 2017-12-31
Polar Capital LLP 345385 1.03% 11755 3.52% 2017-12-31
Rock Springs Capital Management LP 310500 0.92% -- -- 2017-09-30
Renaissance Technologies Corp 186500 0.60% 27900 17.59% 2016-09-30
Allianz Global Investors 192092 0.62% 192092 -- 2016-09-30
Capital World Investors 194244 0.63% -- -- 2016-09-30
共同基金持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
American Funds SMALLCAP World Fund 265244 0.76% -- -- 2019-06-30
Vanguard Total Stock Market Index Fund 860743 2.48% 30 -- 2019-06-30
Vanguard Small Cap Index 799304 2.30% -12288 -1.51% 2019-06-30
Fidelity Growth Company Commingled Pool 751952 2.16% -- -- 2019-06-30
Morgan Stanley Inst Growth Port 650045 1.87% 650045 -- 2019-03-31
ClearBridge Small Cap Growth Fund 553563 1.59% 76760 16.10% 2019-06-30
Hartford Growth Opportunities Fund 515022 1.48% -- -- 2019-06-30
Vanguard Small Cap Growth Index Fund 458043 1.32% -3506 -0.76% 2019-06-30
Vanguard Extended Market Index Fund 429798 1.24% -329 -0.08% 2019-06-30
Vanguard Explorer Fund 418610 1.21% 27934 7.15% 2019-03-31
Fidelity 275392 0.79% -- -- 2019-06-30
Hartford Capital Appreciation Fund 289492 0.83% -- -- 2019-06-30
AXA LE Baillie Gifford American 293080 0.84% -- -- 2019-05-31
Vanguard US Growth Portfolio 303288 0.87% 100072 49.24% 2019-03-31
T. Rowe Price Health Sciences Fund 379898 1.09% 22500 6.30% 2019-06-30
Putnam Sustainable Leaders Fund 388062 1.12% -- -- 2019-03-31
Fidelity Advisor 390000 1.12% -- -- 2019-06-30
Invesco Mid Cap Growth Trust 276775 0.80% 272884 7013.21% 2018-09-30
Invesco Mid Cap Growth Fund 307800 0.89% 52641 20.63% 2019-03-31
Baillie Gifford American Fund 293080 0.84% -3851 -1.30% 2019-04-30
Vanguard Small Cap Index Fund 811167 2.34% 5909 0.73% 2019-04-30
Oppenheimer Discovery Fund 268970 0.77% -- -- 2019-03-31
Lord Abbett Growth Leaders Fund 272464 0.78% -24668 -8.30% 2019-02-28
iShares Russell 2000 Growth ETF 294632 0.85% 508 0.17% 2018-06-21
iShares Russell 2000 ETF 638339 1.84% 7918 1.26% 2018-06-21
VA CollegeAmerica SMALLCAP Wld Fd 265244 0.77% -- -- 2018-12-31
Lord Abbett Developing Growth Fund 257253 0.74% 3771 1.49% 2018-12-31
RI CBF Dir AllianceBern Discovery Gr 253965 0.74% 3450 1.38% 2018-12-31
Polar Capital Healthcare Opps Fund 345385 1.00% 11755 3.52% 2017-12-31
ClearBridge Small Cap Growth A 358989 1.04% 3900 1.10% 2018-07-31
Federated Kaufmann R 250000 0.73% -119300 -32.30% 2018-06-30
T. Rowe Price Health Sciences 250698 0.73% 49400 24.54% 2018-06-30
Lord Abbett Developing Growth A 251882 0.73% -46232 -15.51% 2018-07-31
Vanguard Total Stock Mkt Idx 775150 2.25% 874 0.11% 2018-07-31
Vanguard Small Cap Growth Index Inv 443180 1.29% 6790 1.56% 2018-07-31
Vanguard Extended Market Idx Inv 398896 1.16% 3600 0.91% 2018-07-31
Eagle Small Cap Growth A 361292 1.05% -- -- 2018-06-30
Champlain Small Company Fund 345360 1.00% 64190 22.83% 2018-08-31
Putnam Multi-Cap Growth A 342962 1.00% -- -- 2018-06-30
Vanguard Explorer Inv 309340 0.90% 9520 3.18% 2018-06-30
Invesco Mid Cap Growth A 282075 0.82% -60354 -17.63% 2018-06-30
VA CollegeAmerica Smcap World 529E 265244 0.77% -- -- 2018-06-30
Invesco Mid Cap Growth 282075 0.82% 278184 7149.42% 2018-06-30
Columbia Acorn Z 216000 0.63% -29500 -12.02% 2018-05-31
RI CBF AllianceBern Discovery Gr RA 205319 0.60% -15950 -7.21% 2018-05-31
Oppenheimer Discovery A 192380 0.56% -6720 -3.38% 2018-05-31
iShares Russell 2000 Growth 294632 0.81% 508 0.17% 2018-06-21
American Century Growth Inv 239044 0.70% -- -- 2018-03-31
AB Small Cap Growth A 197415 0.62% -18190 -8.44% 2016-12-31
Oak Ridge Small Cap Growth A 205000 0.65% 205000 -- 2016-11-30
Morgan Stanley Inst Small Co Gr I 174846 0.56% -14208 -7.52% 2016-09-30
Janus Global Life Sciences Fund 87340 -- 87340 -- 2015-09-30
Franklin DynaTech 24900 -- 24900 -- 2015-09-30
Prudential Jennison Health Sciences 23173 -- 23173 -- 2015-09-30
Prudential Jennison Small Company 20530 -- 20530 -- 2015-09-30
Franklin Small Mid Cap Growth VIP Fund 19400 -- 19400 -- 2015-09-30
PrimeCap Odyssey Aggressive Growth Fund 17800 -- 17800 -- 2015-09-30
Principal SmallCap Growth Fund I 15664 -- 15664 -- 2015-09-30
AST Small Cap Growth Opportunities Port 10360 -- 10360 -- 2015-09-30
ClearBridge Variable Small Cap Gr Port 8021 -- 8021 -- 2015-09-30
MassMutual Select Small Cap Growth Eq 7690 -- 7690 -- 2015-09-30
Artisan Global Small Cap Fund 5000 -- 5000 -- 2015-09-30
Franklin Small-Mid Cap Growth Fund 116800 -- 116800 -- 2015-09-30

David Barry David Barry holds the position of Chief Technology Officer for Penumbra, Inc. In his past career he occupied the position of Vice President-Research & Development for Smart Therapeutics, Inc. Mr. Barry received an undergraduate degree from Northeastern University.
Thomas C. Wilder Thomas C. Wilder is a businessperson who has been at the head of 5 different companies. Presently, he holds the position of President & Chief Executive Officer for Neuros Medical, Inc. He is also on the board of Endologix, Inc. and Penumbra, Inc. In his past career he was President & Chief Executive Officer at PhotoThera, Inc., President & Chief Executive Officer at Micro Therapeutics, Inc., President & Chief Executive Officer of Sequent Medical, Inc., President of ev3, Inc., Vice President-Finance & Information Technology at Medtronic Vascular, Inc. and VP & GM-Endovascular Stent Grafts Division at Medtronic, Inc. Mr. Wilder received an undergraduate degree from Stanford University and an MBA from Kellogg School of Management.
Harpreet S. Grewal Currently, Harpreet S. Grewal occupies the position of Treasurer & Director at CardStar, Inc. He is also on the board of Penumbra, Inc. He previously occupied the position of Chief Financial Officer of eGain Corp., Chief Financial Officer for TheLadders.com, Inc., Chief Financial Officer of GoldenSource Corp., Principal at PepsiCo, Inc., Principal at Wasserstein Perella & Co., Inc., Chief Financial Officer & Executive Vice President at VistaPrint Ltd. and General Manager for Constant Contact, Inc. He received an undergraduate degree from the University of California, Berkeley and a graduate degree from The Paul H. Nitze School of Advanced International Studies.
Adam Elsesser Adam Elsesser founded Penumbra, Inc. Presently, he is Chairman, President & Chief Executive Officer at this company and President & Chief Executive Officer for MVI Health, Inc. (a subsidiary of Penumbra, Inc.). He is also on the board of Acumen Medical, Inc. and Lick-Wilmerding High School. In his past career he held the position of President for Boston Scientific SMART, Partner at Shartsis Friese & Ginsburg LLP and President & Chief Executive Officer at Smart Therapeutics, Inc. He received an undergraduate degree from Stanford University and a graduate degree from Hastings College.
Arani Bose Arani Bose founded Penumbra, Inc. and Smart Therapeutics, Inc. Dr. Bose is on the board of Penumbra, Inc. (former Chairman & Chief Medical Officer) and Senior Member at American Academy of Neurology and Director-Stroke Research at Lenox Hill Hospital. In his past career Dr. Bose was Assistant Professor at New York University School of Medicine. Arani Bose received an undergraduate degree from Stanford University and a doctorate from The University of Colorado School of Medicine.
David Barry David Barry holds the position of Chief Technology Officer for Penumbra, Inc. In his past career he occupied the position of Vice President-Research & Development for Smart Therapeutics, Inc. Mr. Barry received an undergraduate degree from Northeastern University.
Don W. Kassing Don W. Kassing is on the board of Penumbra, Inc. and San Jose State University (former President). In his past career Mr. Kassing held the position of Principal at Eastfield No. 23 Ltd., Principal at General Motors Corp., Principal at Murray State University (Kentucky) and Vice President-Development & Public Affairs at Western State College of Colorado. He received an MBA and an undergraduate degree from St. Louis University.
Kathleen Kidd Currently, Kathleen Kidd occupies the position of Vice President-Quality & Compliance at Penumbra, Inc. In the past Ms. Kidd was Principal at Chiron Corp. and Senior Auditor at KEMA NV. Ms. Kidd received an undergraduate degree from Mills College.
Lynn Rothman Lynn Rothman holds the position of Chief Business Officer & Executive VP at Penumbra, Inc. In her past career Ms. Rothman held the position of Principal at Robertson Stephens & Co. and Principal at Confer Software, Inc. She received an undergraduate degree from Stanford University and an MBA from The Wharton School of the University of Pennsylvania.
Ryan Powers Ryan Powers is Vice President-Operations CPIM at Penumbra, Inc.
Surbhi Sarna Founder of nVision Medical Corp., Surbhi Sarna is still Chief Executive Officer at this company. Ms. Sarna is also on the board of Penumbra, Inc. Ms. Sarna received an undergraduate degree from the University of California, Berkeley.
Sridhar Kosaraju Presently, Sridhar Kosaraju holds the position of CFO & Principal Accounting Officer at Penumbra, Inc. Mr. Kosaraju previously occupied the position of Managing Director-Equity Capital Markets at JPMorgan Securities LLC. He received an undergraduate degree from Massachusetts Institute of Technology.
Daniel D. Davis Daniel D. Davis is Chief Commercial Officer at Penumbra, Inc. Mr. Davis received an undergraduate degree from Duke University.
Sharon Hughes Presently, Sharon Hughes is Vice President-Human Resources of Penumbra, Inc. In her past career Ms. Hughes held the position of Director-Human Resources at Lifescan, Inc., Vice President-Human Resources for Complete Genomics, Inc., Head-Human Resources at Janssen Alzheimer Immunotherapy and Head-Human Resources for Elan Pharmaceuticals, Inc. Ms. Hughes received an undergraduate degree from California Polytechnic State University (San Luis Obispo) and an MBA from San Jose State University.
Seth Schulman Presently, Seth Schulman holds the position of Vice President-Regulatory Affairs at Penumbra, Inc. Mr. Schulman received an undergraduate degree from Tufts University.
Pankaj Tiwari Pankaj Tiwari occupies the position of Vice President-Information Technology for Penumbra, Inc. In his past career he was Vice President-Information Technology for Nanosolar, Inc., Director-Business Applications at Marvell Semiconductor, Inc. and Senior Director-Global Business Application at Atmel Corp. Mr. Tiwari received an MBA from California State University-East Bay and an undergraduate degree from Banaras Hindu University.
Ben Tompkins Ben Tompkins occupies the position of Vice President-Research & Development for Penumbra, Inc. He received an undergraduate degree and a graduate degree from the University of California, Davis.
Gita Barry Currently, Gita Barry holds the position of Vice President-Global Marketing at Penumbra, Inc. Ms. Barry received an undergraduate degree from the University of Miami and an MBA from Santa Clara University.
Bridget O'Rourke Bridget O'Rourke is on the board of Penumbra, Inc. and San Francisco Fire Credit Union. In her past career she occupied the position of Controller at Sigma Partners, Head-Human Resources of Passport Capital LLC and Vice President at Citigroup Asset Management. She received an undergraduate degree from the University of California.
Michaella Corso Michaella Corso is Vice President-Clinical Affairs at Penumbra, Inc. She received an undergraduate degree from the University of California, Los Angeles.
Johanna Roberts Johanna Roberts is Secretary, Executive VP & General Counsel of Penumbra, Inc. She received a graduate degree from Harvard Law School and an undergraduate degree from Dartmouth College.
Johanna Roberts Johanna Roberts is Secretary, Executive VP & General Counsel of Penumbra, Inc. She received a graduate degree from Harvard Law School and an undergraduate degree from Dartmouth College.
Janet Leeds Janet Leeds is on the board of Penumbra, Inc. and Administrative Director at Seattle Cancer Care Alliance. She previously was Director-Planning at Fred Hutchinson Cancer Research Center. She received an undergraduate degree from Stanford University and an MBA from the University of Washington.

量化对比

全部评论 0

  • 暂无评论

阿布量化公众号二维码 abu_quant 扫一扫关注阿布量化

热门推荐